XERENDIP INY 4UI FAM C/1 KETOCONAZOL CAJA C/10 (KETOROLACO)

Description

CAJA C/10 (KETOROLACO)

indicado para el tratamiento de la leucemia promielocítica aguda (LPA)

DOSIS: 25 G

FABRICANTE: QUIFA - PERRIGO OTC

Suspensión

XERENDIP INY 4UI FAM C/1 KETOCONAZOL CAJA C/10 (KETOROLACO)PRINCIPIO ACTIVO: SOMATROPINA

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy